CD326, Human (Oportuzumab Monatox biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD326, Human (Oportuzumab Monatox biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD326, Human (Oportuzumab Monatox biosimilar)
CloneOportuzumab Monatox
Host SpeciesRecombinant
Reactive Specieshuman
IsotypescFv kappa-heavy
FormatscFv fragment
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD326 Recombinant Antibody (Oportuzumab Monatox). Oportuzumab monatox (proposed INN, trade name Vicineum) is an antineoplastic. Chemically, oportuzumab is a single chain variable fragment of a monoclonal antibody which binds to epithelial cell adhesion molecule (EpCAM, the tumor-associated calcium signal transducer 1).
Immunogenn/a
Other NamesAnti-CD326 Recombinant Antibody, Research Grade Oportuzumab Monatox, Anti-Human CD326 Recombinant Antibody(Oportuzumab Monatox), VB4-845, Antibody Drug Analogues, Monoclonal Antibody, YR1637, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 945228-48-8
Catalog #YR1637
Priceplease inquire
Order / More InfoCD326, Human (Oportuzumab Monatox biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.